dr. T. van Meerten

No picture available
t.van.meerten umcg.nl


  1. Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands

    van Doesum, J., Chinea, A., Pagliaro, M., Pasquini, M. C., van Meerten, T., Bakker, M. & Ammatuna, E., Sep-2020, In : Leukemia. 34, 9, p. 2536-2538 3 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  2. Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study

    Morello, L., Rattotti, S., Giordano, L., Jerkeman, M., van Meerten, T., Krawczyk, K., Moita, F., Marino, D., Ferrero, S., Szymczyk, M., Aurer, I., El-Galaly, T. C., Di Rocco, A., Visco, C., Carli, G., Defrancesco, I., Carlo-Stella, C., Dreyling, M., Santoro, A. & Arcaini, L., Feb-2020, In : HemaSphere. 4, 1, 6 p., 302.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma

    de Jong, M. R. W., Langendonk, M., Reitsma, B., Herbers, P., Lodewijk, M., Nijland, M., van den Berg, A., Ammatuna, E., Visser, L. & van Meerten, T., Jan-2020, In : Therapeutic advances in hematology. 11, p. 2040620719898373 14 p., 2040620719898373.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (24) »

ID: 50288891